Free Trial

This company has been marked as potentially delisted and may not be actively trading.

OmniLit Acquisition (OLIT) Competitors

OmniLit Acquisition logo

OLIT vs. MSAI, CLIR, DAIO, AXDX, ASTC, BNGO, STAI, PRPO, TLIS, and TBIO

Should you be buying OmniLit Acquisition stock or one of its competitors? The main competitors of OmniLit Acquisition include MultiSensor AI (MSAI), ClearSign Technologies (CLIR), Data I/O (DAIO), Accelerate Diagnostics (AXDX), Astrotech (ASTC), Bionano Genomics (BNGO), Scantech AI Systems (STAI), Precipio (PRPO), Talis Biomedical (TLIS), and Telesis Bio (TBIO). These companies are all part of the "measuring and control equipment" industry.

OmniLit Acquisition vs.

MultiSensor AI (NASDAQ:MSAI) and OmniLit Acquisition (NASDAQ:OLIT) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability, media sentiment and community ranking.

In the previous week, MultiSensor AI had 1 more articles in the media than OmniLit Acquisition. MarketBeat recorded 1 mentions for MultiSensor AI and 0 mentions for OmniLit Acquisition. MultiSensor AI's average media sentiment score of 1.87 beat OmniLit Acquisition's score of 0.00 indicating that MultiSensor AI is being referred to more favorably in the media.

Company Overall Sentiment
MultiSensor AI Very Positive
OmniLit Acquisition Neutral

MultiSensor AI presently has a consensus target price of $5.25, suggesting a potential upside of 506.94%. Given MultiSensor AI's stronger consensus rating and higher possible upside, equities analysts clearly believe MultiSensor AI is more favorable than OmniLit Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MultiSensor AI
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
OmniLit Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

MultiSensor AI has a beta of -0.44, meaning that its stock price is 144% less volatile than the S&P 500. Comparatively, OmniLit Acquisition has a beta of 0.05, meaning that its stock price is 95% less volatile than the S&P 500.

82.3% of MultiSensor AI shares are held by institutional investors. Comparatively, 21.6% of OmniLit Acquisition shares are held by institutional investors. 45.5% of MultiSensor AI shares are held by insiders. Comparatively, 78.0% of OmniLit Acquisition shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

MultiSensor AI received 4 more outperform votes than OmniLit Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
MultiSensor AIOutperform Votes
4
100.00%
Underperform Votes
No Votes
OmniLit AcquisitionN/AN/A

OmniLit Acquisition has lower revenue, but higher earnings than MultiSensor AI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MultiSensor AI$7.40M3.85-$22.27MN/AN/A
OmniLit AcquisitionN/AN/AN/AN/AN/A

OmniLit Acquisition has a net margin of 0.00% compared to MultiSensor AI's net margin of -464.06%. OmniLit Acquisition's return on equity of 0.00% beat MultiSensor AI's return on equity.

Company Net Margins Return on Equity Return on Assets
MultiSensor AI-464.06% -668.81% -185.62%
OmniLit Acquisition N/A N/A N/A

Summary

MultiSensor AI beats OmniLit Acquisition on 8 of the 13 factors compared between the two stocks.

Remove Ads
Get OmniLit Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for OLIT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OLIT vs. The Competition

MetricOmniLit AcquisitionHolding Offices Industry SectorNASDAQ Exchange
Market Cap$6.57M$434.14M$2.35B$7.53B
Dividend YieldN/A7.99%13.18%4.30%
P/E RatioN/A2.3411.0517.70
Price / SalesN/A47.822,973,075.4393.45
Price / CashN/A69.0154.8834.64
Price / BookN/A3.283.083.89
Net IncomeN/A$35.22M-$300.27M$247.17M

OmniLit Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OLIT
OmniLit Acquisition
N/A$1.07
-7.0%
N/A-66.0%$6.57MN/A0.003Gap Up
MSAI
MultiSensor AI
3.5251 of 5 stars
$0.90
-5.4%
$5.25
+485.8%
-69.7%$28.79M$7.62M0.0035Positive News
CLIR
ClearSign Technologies
1.9512 of 5 stars
$0.50
-18.4%
$6.00
+1,100.0%
-42.7%$25.12M$4.28M-4.5510Analyst Forecast
News Coverage
Gap Down
High Trading Volume
DAIO
Data I/O
2.274 of 5 stars
$2.35
-2.9%
$4.00
+70.2%
-43.4%$21.71M$21.77M-12.37100News Coverage
High Trading Volume
AXDX
Accelerate Diagnostics
2.0303 of 5 stars
$0.65
-6.5%
N/A-34.8%$16.39M$11.70M-0.23220Analyst Forecast
Gap Up
High Trading Volume
ASTC
Astrotech
0.7887 of 5 stars
$6.34
+0.7%
N/A-36.3%$10.78M$419,000.00-0.7810
BNGO
Bionano Genomics
1.3544 of 5 stars
$3.03
-9.8%
$62.00
+1,946.2%
-92.9%$8.28M$33.33M-0.02300Analyst Forecast
Analyst Revision
STAI
Scantech AI Systems
N/A$1.78
-12.3%
N/AN/A$7.96M$522,166.000.00N/A
PRPO
Precipio
1.1225 of 5 stars
$5.27
+2.3%
N/A-19.3%$7.81M$17.41M-2.8860Gap Down
TLIS
Talis Biomedical
N/A$1.56
-10.6%
N/A-82.4%$2.84M$300,000.00-0.06260Gap Down
TBIO
Telesis Bio
N/A$0.43
+53.5%
N/A-85.7%$775,000.00$225.09M-0.02200Gap Up
High Trading Volume
Remove Ads

Related Companies and Tools


This page (NASDAQ:OLIT) was last updated on 4/11/2025 by MarketBeat.com Staff
From Our Partners